<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Bhuiyan TR</submitter><pubmed_abstract>Coronavirus disease 2019 (COVID-19) is a protean disease causing different degrees of clinical severity including fatality. In addition to humoral immunity, antigen-specific T cells may play a critical role in defining the protective immune response against SARS-CoV-2, the virus that causes this disease. As a part of a longitudinal cohort study in Bangladesh to investigate B and T cell-specific immune responses, we sought to evaluate the activation-induced marker (AIM) and the status of different immune cell subsets during a COVID-19 infection. We analyzed a total of 115 participants, which included participants with asymptomatic, mild, moderate, and severe clinical symptoms. We observed decreased mucosal-associated invariant T (MAIT) cell frequency on the initial days of the COVID-19 infe</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>929849</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9554593</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.</pubmed_title><pmcid>PMC9554593</pmcid><pubmed_authors>Islam S</pubmed_authors><pubmed_authors>Sumon MA</pubmed_authors><pubmed_authors>Sette A</pubmed_authors><pubmed_authors>Qadri F</pubmed_authors><pubmed_authors>Bhuiyan TR</pubmed_authors><pubmed_authors>Akter A</pubmed_authors><pubmed_authors>Ahmed T</pubmed_authors><pubmed_authors>Rashed A</pubmed_authors><pubmed_authors>Chowdhury F</pubmed_authors><pubmed_authors>Karmakar PC</pubmed_authors><pubmed_authors>Hakim A</pubmed_authors><pubmed_authors>Clemens JD</pubmed_authors><pubmed_authors>Hasnat MA</pubmed_authors><pubmed_authors>Ghosh S</pubmed_authors><pubmed_authors>Weiskopf D</pubmed_authors><pubmed_authors>Banu S</pubmed_authors><pubmed_authors>Al Banna H</pubmed_authors><pubmed_authors>Shirin T</pubmed_authors><pubmed_authors>Tauheed I</pubmed_authors><pubmed_authors>Kaisar MH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.</name><description>Coronavirus disease 2019 (COVID-19) is a protean disease causing different degrees of clinical severity including fatality. In addition to humoral immunity, antigen-specific T cells may play a critical role in defining the protective immune response against SARS-CoV-2, the virus that causes this disease. As a part of a longitudinal cohort study in Bangladesh to investigate B and T cell-specific immune responses, we sought to evaluate the activation-induced marker (AIM) and the status of different immune cell subsets during a COVID-19 infection. We analyzed a total of 115 participants, which included participants with asymptomatic, mild, moderate, and severe clinical symptoms. We observed decreased mucosal-associated invariant T (MAIT) cell frequency on the initial days of the COVID-19 infe</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-18T22:52:36.027Z</modification><creation>2025-04-07T10:38:22.065Z</creation></dates><accession>S-EPMC9554593</accession><cross_references><pubmed>36248882</pubmed><doi>10.3389/fimmu.2022.929849</doi></cross_references></HashMap>